Board Meeting13 Aug 2026, 05:24 pm
Decipher Labs Approves Q1 FY27 Un-Audited Results, Appoints Director
AI Summary
Decipher Labs Limited held its Board Meeting on August 13, 2026, to approve the un-audited financial results for the quarter ended June 30, 2026. The company also approved the Limited Review Report for the same period. Additionally, the Board appointed Mr. Bhupendralal Waghray as an Additional Director (Independent Category) for a term of five years, subject to shareholder approval. The meeting concluded with the approval of these key items.
Key Highlights
- Board approved un-audited financial results for Q1 FY27.
- Limited Review Report for Q1 FY27 also approved.
- Mr. Bhupendralal Waghray appointed as Additional Director.
- Director appointment is for five years, subject to member approval.
- Company formerly known as Combat Drugs Limited.
Price Impact
More from DECIPHER